- Home
- SGMT vs OM Comparison
SGMT vs OM Comparison
Compare SGMT & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- OM
- Stock Information
- Founded
- SGMT 2006
- OM 2003
- Country
- SGMT United States
- OM United States
- Employees
- SGMT N/A
- OM N/A
- Industry
- SGMT
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SGMT
- OM Health Care
- Exchange
- SGMT Nasdaq
- OM Nasdaq
- Market Cap
- SGMT 238.7M
- OM 247.1M
- IPO Year
- SGMT 2023
- OM 2020
- Fundamental
- Price
- SGMT $7.31
- OM $15.87
- Analyst Decision
- SGMT Strong Buy
- OM Hold
- Analyst Count
- SGMT 7
- OM 1
- Target Price
- SGMT $26.57
- OM $22.00
- AVG Volume (30 Days)
- SGMT 480.3K
- OM 168.6K
- Earning Date
- SGMT 11-12-2025
- OM 11-05-2025
- Dividend Yield
- SGMT N/A
- OM N/A
- EPS Growth
- SGMT N/A
- OM N/A
- EPS
- SGMT N/A
- OM N/A
- Revenue
- SGMT N/A
- OM $119,304,000.00
- Revenue This Year
- SGMT N/A
- OM $12.37
- Revenue Next Year
- SGMT N/A
- OM $10.52
- P/E Ratio
- SGMT N/A
- OM N/A
- Revenue Growth
- SGMT N/A
- OM 2.47
- 52 Week Low
- SGMT $1.73
- OM $5.85
- 52 Week High
- SGMT $11.41
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- SGMT 52.06
- OM 60.72
- Support Level
- SGMT $7.11
- OM $13.59
- Resistance Level
- SGMT $7.66
- OM $15.08
- Average True Range (ATR)
- SGMT 0.40
- OM 0.84
- MACD
- SGMT 0.11
- OM 0.12
- Stochastic Oscillator
- SGMT 76.45
- OM 71.60
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.